相关实验视频

Updated: Jul 10, 2025

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

通过IFNγ多因素重塑癌症免疫体的IFNγγ

Alice Newey^1,2, Lu Yu², Louise J Barber^1,2

¹Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.

Cancer research communications

|November 22, 2023

概括

干扰素- (IFNγ) 修改了癌细胞在HLA类I (HLA-I) 上呈现的. 含有proline的被优先下调,影响免疫疗法标选择.

科学领域:

免疫学免疫学免疫学
癌症生物学癌症生物学
蛋白质组学是指蛋白质组学.

背景情况:

干扰素- (IFNγ) 通过改变HLA类I (HLA-I) 上呈现的免疫组,对有效的癌症免疫疗法至关重要.
了解IFNγ介导的免疫体重塑是确定抗原特异性癌症免疫疗法的最佳点的关键.

研究的目的:

在结直肠癌中剖析IFNγ诱导的免疫体重塑背后的机制.
确定影响HLA-I丰度变化的特异性因素.

主要方法:

用IFNγ治疗的患者衍生的结直肠癌器官的蛋白质组,转录组和HLA-I免疫组分析.
生物信息分析以将蛋白质丰富度,蛋白酶活性,HLA等位基因表达和特征与观察到的免疫组变化相关联.

主要成果:

IFNγ治疗显著重塑了免疫群,源蛋白丰度的变化和蛋白酶体切换只解释了部分变化的部分原因.
特异性因素,特别是氨基酸组成,显著影响了HLA-I上调或下调.
核心区域中含有プロ林的被优先下调,独立于预测的HLA-I结合亲和力或稳定性.

结论:

IFNγ诱导的免疫组变化是多因素的,涉及蛋白质来源,蛋白酶体活性,HLA等位基因表达和序列.
在的核心中存在素是一个重要的因素,驱动其对HLA-I的下调.
这些发现对于选择可靠的抗原点来进行癌症免疫疗法至关重要,例如疫苗和T细胞受体工程疗法.

更多相关视频

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...